A detailed history of Wells Fargo & Company transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,507 shares of AKYA stock, worth $21,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,507
Previous 6,926 22.83%
Holding current value
$21,777
Previous $32,000 40.63%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.94 - $4.56 $3,067 - $7,209
1,581 Added 22.83%
8,507 $19,000
Q1 2024

May 10, 2024

BUY
$4.33 - $6.06 $4,022 - $5,629
929 Added 15.49%
6,926 $32,000
Q4 2023

Feb 09, 2024

BUY
$3.13 - $5.13 $4,820 - $7,900
1,540 Added 34.55%
5,997 $29,000
Q3 2023

Nov 13, 2023

SELL
$4.24 - $7.44 $13,529 - $23,741
-3,191 Reduced 41.72%
4,457 $20,000
Q2 2023

Aug 15, 2023

BUY
$5.28 - $8.35 $22,044 - $34,861
4,175 Added 120.21%
7,648 $56,000
Q1 2023

May 12, 2023

BUY
$7.6 - $12.68 $22,746 - $37,951
2,993 Added 623.54%
3,473 $28,000
Q4 2022

Feb 13, 2023

SELL
$8.6 - $14.1 $2,141 - $3,510
-249 Reduced 34.16%
480 $4,000
Q3 2022

Nov 14, 2022

SELL
$10.63 - $15.76 $3,709 - $5,500
-349 Reduced 32.37%
729 $8,000
Q2 2022

Aug 12, 2022

SELL
$8.38 - $12.85 $991,387 - $1.52 Million
-118,304 Reduced 99.1%
1,078 $14,000
Q1 2022

May 16, 2022

BUY
$9.84 - $14.97 $10,046 - $15,284
1,021 Added 0.86%
119,382 $1.31 Million
Q4 2021

Feb 14, 2022

SELL
$11.37 - $15.31 $2.6 Million - $3.5 Million
-228,478 Reduced 65.87%
118,361 $1.81 Million
Q3 2021

Nov 15, 2021

BUY
$13.04 - $21.0 $1.64 Million - $2.65 Million
126,062 Added 57.1%
346,839 $4.84 Million
Q2 2021

Aug 16, 2021

BUY
$17.89 - $26.05 $3.95 Million - $5.75 Million
220,777 New
220,777 $4.27 Million

Others Institutions Holding AKYA

About Akoya Biosciences, Inc.


  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $97M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.